| MET is required for the recruitment of anti-tumoural neutrophils V Finisguerra, G Di Conza, M Di Matteo, J Serneels, S Costa, ... Nature 522 (7556), 349-353, 2015 | 436 | 2015 |
| Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis Y Takeda, S Costa, E Delamarre, C Roncal, R Leite de Oliveira, ... Nature 479 (7371), 122-126, 2011 | 317 | 2011 |
| Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment A Casazza, G Di Conza, M Wenes, V Finisguerra, S Deschoemaeker, ... Oncogene 33 (14), 1743-1754, 2014 | 273 | 2014 |
| Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice A Casazza, V Finisguerra, L Capparuccia, A Camperi, JM Swiercz, ... The Journal of clinical investigation 120 (8), 2684-2698, 2010 | 190 | 2010 |
| Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity RL de Oliveira, S Deschoemaeker, AT Henze, K Debackere, ... Cancer cell 22 (2), 263-277, 2012 | 137 | 2012 |
| Transferrin receptor 2 is frequently and highly expressed in glioblastomas A Calzolari, LM Larocca, S Deaglio, V Finisguerra, A Boe, C Raggi, ... Translational oncology 3 (2), 123-134, 2010 | 130 | 2010 |
| Preclinical murine tumor models: a structural and functional perspective MV Guerin, V Finisguerra, BJ Van den Eynde, N Bercovici, A Trautmann Elife 9, e50740, 2020 | 107 | 2020 |
| Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism AAR Thompson, RS Dickinson, F Murphy, JP Thomson, HM Marriott, ... Science immunology 2 (8), eaal2861, 2017 | 73 | 2017 |
| TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors MV Guerin, F Regnier, V Feuillet, L Vimeux, JM Weiss, G Bismuth, ... Nature communications 10 (1), 4131, 2019 | 45 | 2019 |
| Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma V Finisguerra, H Prenen, M Mazzone Oncogene 35 (42), 5457-5467, 2016 | 32 | 2016 |
| Regulation of transferrin receptor 2 in human cancer cell lines A Calzolari, V Finisguerra, I Oliviero, S Deaglio, G Mariani, F Malavasi, ... Blood Cells, Molecules, and Diseases 42 (1), 5-13, 2009 | 16 | 2009 |
| Is There Merit for MET-Targeted Therapies in Gastroesophageal Cancer? M Mazzone, V Finisguerra, H Prenen JAMA oncology 4 (1), 131-132, 2018 | 2 | 2018 |
